R Ganschow, L Pape, E Sturm, J Bauer… - Pediatric …, 2013 - Wiley Online Library
Controlled trials of m TOR inhibitors in children following solid organ transplantation are scarce, although evidence from prospective single‐arm studies is growing. Everolimus with …
Maintenance therapy with calcineurin inhibitors (CNIs) increases cardiovascular risk. Use of the m‐TOR inhibitors everolimus or sirolimus to minimize CNI exposure is usually …
Prospective data regarding the de novo use of everolimus following kidney transplantation in children are sparse. In a prospective, 12‐month, single‐arm, open‐label study, pediatric …
A Chen, JJ Lin, AM South - Kidney Transplantation, Bioengineering and …, 2017 - Elsevier
Kidney transplantation is the treatment of choice for pediatric patients with end-stage renal disease. With the advance in immunosuppression, surgical techniques, and posttransplant …
BACKGROUND The following background has been based on that provided in the KDIGO guideline and edited to reflect review conducted for the adaptation.(BK polyoma virus (BKV) …